Is Serum Brain-Derived Neurotrophic Factor a Biomarker for Cognitive Enhancement in Schizophrenia?

Biological Psychiatry

Volumn 66, Issue 6, 2009, Pages 549-553

  Vinogradov, Sophia ^a,b   Fisher, Melissa ^a,b   Holland, Christine ^a,b   Shelly, Wendy ^a   Wolkowitz, Owen ^a   Mellon, Synthia H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BDNF; biomarker; cognitive enhancement cognitive remediation; cognitive training; neuroplasticity; schizophrenia

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ARTICLE; AUDITORY TRAINING; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH CARE QUALITY; HEARING; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CELL PLASTICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; COGNITION DISORDERS; COGNITIVE THERAPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; THERAPY, COMPUTER-ASSISTED; TIME FACTORS;

EID: 68949188168     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.02.017     Document Type: Article

References (39)

1. Gorski J.A., Zeiler S.R., Tamowski S., and Jones K.R. Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurol Sci 23 (2003) 6856-6865
2. Huang Z.J., Kirkwood A., Pizzorusso T., Porciatti V., Morales B., Bear M.F., et al. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 98 (1999) 739-755
3. Buckley P.F., Mahadik S., Pillai A., and Terry Jr. A. Neurotrophins and schizophrenia. Schizophr Res 94 (2007) 1-11
4. Iritani S., Niizato K., Nawa H., Ikeda K., and Emson P.C. Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 801-807
5. Durany N., Michel T., Zochling R., Boissl K.W., Cruz-Sanchez F.F., Riederer P., et al. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 52 (2001) 79-86
6. Cannon T.D., Yolken R., Buka S., and Torrey E.F. Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia. Biol Psychiatry 64 (2008) 797-802
7. Rizos E.N., Rontos I., Laskos E., Arsenis G., Michalopoulou P.G., Vasilopoulos D., et al. Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1308-1311
8. Grillo R.W., Ottoni G.L., Leke R., Souza D.O., Portela L.V., and Lara D.R. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. J Psychiatr Res 41 (2007) 31-35
9. Pirildar S., Gonul A.S., Taneli F., and Akdeniz F. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 709-713
10. Tan Y.L., Zhou D.F., Cao L.Y., Zou Y.Z., and Zhang X.Y. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Neurosci Lett 382 (2005) 27-32
11. Toyooka K., Asama K., Watanabe Y., Muratake T., Takahashi M., Someya T., et al. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 110 (2002) 249-257
12. Shimizu E., Hashimoto K., Watanabe H., Komatsu N., Okamura N., Koike K., et al. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci Lett 351 (2003) 111-114
13. Jockers-Scherubl M.C., Danker-Hopfe H., Mahlberg R., Selig F., Rentzsch J., Schurer F., et al. Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. Neurosci Lett 371 (2004) 79-83
14. Huang T.L., and Lee C.T. Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients. J Psychiatr Res 40 (2006) 664-668
15. Zhang X.Y., Tan Y.L., Zhou D.F., Cao L.Y., Wu G.Y., Xu Q., et al. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics. J Psychiatr Res 41 (2007) 997-1004
16. Gama C.S., Andreazza A.C., Kunz M., Berk M., et al. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci Lett 420 (2007) 45-48
17. Reis H.J., Nicolato R., Barbosa I.G., Teixeira do Prado P.H., Romano-Silva M.A., and Teixeira A.L. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci Lett 439 (2008) 157-159
18. Mizuno M., Yamada K., Olariu A., Nawa H., and Nabeshima T. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. J Neurol Sci 20 (2000) 7116-7121
19. Linnarsson S., Bjorklund A., and Ernfors P. Learning deficit in BDNF mutant mice. Eur J Neurosci 9 (1997) 2581-2587
20. Young D., Lawlor P.A., Leone P., Dragunow M., and During M.J. Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med 5 (1999) 448-453
21. Gervasoni N., Aubry J.M., Bondolfi G., Osiek C., Schwald M., Bertschy G., et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51 (2005) 234-238
22. Lee H.Y., and Kim Y.K. Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 57 (2008) 194-199
23. Huang T.L., Lee C.T., and Liu Y.L. Serum brain-derived neurotrophic factor levels in patients with major depression: Effects of antidepressants. J Psychiatr Res 42 (2008) 521-525
24. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54 (2003) 70-75
25. Sen S., Duman R., and Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Metal-analyses and implications. Biol Psychiatry 64 (2008) 527-532
26. Brunoni A.R., Lopes M., and Fregni F. A systematic review and metal-analysis of clinical studies on major depression and BDNF levels: Implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacology 11 (2008) 1169-1180
27. Fisher M, Holland C, Merzenich M, Vinogradov S (in press): Neuroplasticity-based auditory training improves verbal memory in schizophrenia. Am J Psychiatry.
28. Vinogradov S, Fisher M, Warm H, Holland C, Kirshner MA, Pollock BG (in press): The cognitive cost of anticholinergic burden: Decreased response to cognitive training in schizophrenia. Am J Psychiatry.
29. First M.B., Spitzer R.L., Gibbon M., and Gibbon J.W.B. Structured Clinical Interview for DSM-IV-TR. Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) (2002), Biometrics Research Department, New York State Psychiatric Institute, New York
30. Kay S.R., and Sevy S. Pyramidical model of schizophrenia. Schizophr Bull 16 (1990) 537-545
31. Bilker W.B., Brensinger C., Kurtz M.M., Kohler C., Gur R.C., et al. Development of an abbreviated schizophrenia quality of life scale using a new method. Neuropsychopharmacology 28 (2003) 773-777
32. Deci E.L., Eghrari H., Patrick B.C., and Leone D.R. Facilitating internalization: The self-determination theory perspective. J Pers 62 (1994) 119-142
33. Rizos E.N., Papadopoulou A., Laskos E., Michalopoulou P.G., Kastania A., Vasilopoulos D., et al. Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. World J Biol Psychiatry (2008) 1-5
34. Guimaraes L.R., Jacka F.N., Gama C.S., Berk M., Leitao-Azevedo C.L., et al. Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1595-1598
35. Lee J., Duan W., Long J.M., Ingram D.K., and Mattson M.P. Dietary restriction increases the number of newly generated neural cells, and induces BDNF expression, in the dentate gyrus of rats. J Mol Neurosci 15 (2000) 99-108
36. Lee J., Duan W., and Mattson M.P. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 82 (2002) 1367-1375
37. Karege F., Schwald M., and Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328 (2002) 261-264
38. Lang U.E., Hellweg R., Seifert F., Schubert F., and Gallinat J. Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biol Psychiatry 62 (2007) 530-535
39. Fisher M., Holland C., Subramaniam K., and Vinogradov S. Neuroplasticity-based cognitive training in schizophrenia: What are the effects six months later [published online ahead of print March 5]?. Schizophr Bull (2009)